A citation-based method for searching scientific literature

Yufei Yang, Lingfang Xia, Yong Wu, Hongyu Zhou, Xin Chen, Haoran Li, Midie Xu, Zihao Qi, Ziliang Wang, Huizhen Sun, Xi Cheng. Cancer Commun (Lond) 2021
Times Cited: 5







List of co-cited articles
24 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Microsatellite instability: a review of what the oncologist should know.
Kai Li, Haiqing Luo, Lianfang Huang, Hui Luo, Xiao Zhu. Cancer Cell Int 2020
59
60

The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma.
Xiao Zhu, Jinfang Zhang, Wenguo Fan, Fang Wang, Hong Yao, Zifeng Wang, Shengping Hou, Yinghong Tian, Weiming Fu, Dan Xie,[...]. Carcinogenesis 2013
28
60

Targeting the GRP78 Pathway for Cancer Therapy.
Guanhua Lu, Hui Luo, Xiao Zhu. Front Med (Lausanne) 2020
12
60

New insights into molecules and pathways of cancer metabolism and therapeutic implications.
Zhenye Tang, Zhenhua Xu, Xiao Zhu, Jinfang Zhang. Cancer Commun (Lond) 2021
13
60

piRNAs: biogenesis and their potential roles in cancer.
Binghong Guo, Dongpei Li, Likun Du, Xiao Zhu. Cancer Metastasis Rev 2020
39
60

Cancer neoantigen: Boosting immunotherapy.
Peijia Xu, Haiqing Luo, Ying Kong, Wing-Fu Lai, Liao Cui, Xiao Zhu. Biomed Pharmacother 2020
13
60

Cancer immunotherapy: Pros, cons and beyond.
Shuzhen Tan, Dongpei Li, Xiao Zhu. Biomed Pharmacother 2020
54
60

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
40

Cancer evolution: A means by which tumors evade treatment.
Xiao Zhu, Shi Li, Bairui Xu, Hui Luo. Biomed Pharmacother 2021
6
40

The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Zhilin Zou, Shuguang Zhou, Guosheng Liang, Zhenye Tang, Kai Li, Shuzhen Tan, Xiangsheng Zhang, Xiao Zhu. Mol Omics 2021
4
50

The single-cell sequencing: new developments and medical applications.
Xiaoning Tang, Yongmei Huang, Jinli Lei, Hui Luo, Xiao Zhu. Cell Biosci 2019
58
40

Circular RNAs: The star molecules in cancer.
Jianhong Liu, Dongpei Li, Hui Luo, Xiao Zhu. Mol Aspects Med 2019
76
40

Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully.
Baisheng Lin, Likun Du, Hongmei Li, Xiao Zhu, Liao Cui, Xiaosong Li. Biomed Pharmacother 2020
8
40

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges.
Zhilin Zou, Tao Tao, Hongmei Li, Xiao Zhu. Cell Biosci 2020
82
40

Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art.
Jin Kang, Chao Zhang, Wen-Zhao Zhong. Cancer Commun (Lond) 2021
9
40

CRISPR technology: The engine that drives cancer therapy.
Mingtao Zhang, Emily A Eshraghian, Omar Al Jammal, Zhibi Zhang, Xiao Zhu. Biomed Pharmacother 2021
10
40


How to overcome the side effects of tumor immunotherapy.
Shang Li, Zhibi Zhang, Wing-Fu Lai, Liao Cui, Xiao Zhu. Biomed Pharmacother 2020
8
40

Heme oxygenase-1 system and gastrointestinal inflammation: a short review.
Xiao Zhu, Wen-Guo Fan, Dong-Pei Li, Hsiangfu Kung, Marie Cm Lin. World J Gastroenterol 2011
50
40

GWAS in cancer: progress and challenges.
Baiqiang Liang, Hongrong Ding, Lianfang Huang, Haiqing Luo, Xiao Zhu. Mol Genet Genomics 2020
24
40

Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Luis Enrique Cortés-Hernández, Zahra Eslami-S, Catherine Alix-Panabières. Mol Aspects Med 2020
25
40

RNA-based pharmacotherapy for tumors: From bench to clinic and back.
Xiangping Liang, Dongpei Li, Shuilong Leng, Xiao Zhu. Biomed Pharmacother 2020
25
40


True significance of N-acetylglucosaminyltransferases GnT-III, V and α1,6 fucosyltransferase in epithelial-mesenchymal transition and cancer.
Naoyuki Taniguchi, Yuki Ohkawa, Kento Maeda, Yoichiro Harada, Masamichi Nagae, Yasuhiko Kizuka, Hideyuki Ihara, Yoshitaka Ikeda. Mol Aspects Med 2021
5
40

Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis.
Shuxia Wang, Bo Yuan, Yun Wang, Mingyang Li, Xibo Liu, Jing Cao, Changtian Li, Jihong Hu. Int J Colorectal Dis 2021
3
33

Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer.
Wenhui Zhu, Chunyan Liu, Tongyi Lu, Yinmei Zhang, Simin Zhang, Qi Chen, Ning Deng. Front Oncol 2020
2
50

Ovarian cancer-excreted exosomal miR-199a-5p suppresses tumor metastasis by targeting hypoxia-inducible factor-2α in hypoxia microenvironment.
Xuan-Ye Lian, Hui Zhang, Qun Liu, Xue Lu, Ping Zhou, Shu-Qian He, Rui-Xue Tang, Jing Cui. Cancer Commun (Lond) 2020
1
100

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
J A Ledermann, F A Raja, C Fotopoulou, A Gonzalez-Martin, N Colombo, C Sessa. Ann Oncol 2018
34
20

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Haidong Dong, Scott E Strome, Diva R Salomao, Hideto Tamura, Fumiya Hirano, Dallas B Flies, Patrick C Roche, Jun Lu, Gefeng Zhu, Koji Tamada,[...]. Nat Med 2002
20

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Mary L Disis, Matthew H Taylor, Karen Kelly, J Thaddeus Beck, Michael Gordon, Kathleen M Moore, Manish R Patel, Jorge Chaves, Haeseong Park, Alain C Mita,[...]. JAMA Oncol 2019
141
20

Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Robert A Burger, Mark F Brady, Michael A Bookman, Gini F Fleming, Bradley J Monk, Helen Huang, Robert S Mannel, Howard D Homesley, Jeffrey Fowler, Benjamin E Greer,[...]. N Engl J Med 2011
20

Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.
Shaojia Wang, Jiajia Li, Jie Xie, Fei Liu, Yachen Duan, Yong Wu, Shenglin Huang, Xianghuo He, Ziliang Wang, Xiaohua Wu. Oncogene 2018
40
20

Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.
Dalong Cao, Zihao Qi, Yangyang Pang, Haoran Li, Huyang Xie, Junlong Wu, Yongqiang Huang, Yao Zhu, Yijun Shen, Yiping Zhu,[...]. Cancer Res 2019
25
20

Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
Jonathan Welti, Sonja Loges, Stefanie Dimmeler, Peter Carmeliet. J Clin Invest 2013
378
20

Bevacizumab use in the frontline, maintenance and recurrent settings for ovarian cancer.
Carolyn E Haunschild, Krishnansu S Tewari. Future Oncol 2020
10
20

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.
Qiang Gao, Xiao-Ying Wang, Shuang-Jian Qiu, Ichiro Yamato, Masayuki Sho, Yoshiyuki Nakajima, Jian Zhou, Bai-Zhou Li, Ying-Hong Shi, Yong-Sheng Xiao,[...]. Clin Cancer Res 2009
530
20

PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway.
Rui Zhao, Yinghan Song, Yong Wang, Yuqian Huang, Zhigui Li, Yaping Cui, Mengshi Yi, Lin Xia, Wen Zhuang, Xiaoting Wu,[...]. Cell Prolif 2019
37
20

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Carol Aghajanian, Stephanie V Blank, Barbara A Goff, Patricia L Judson, Michael G Teneriello, Amreen Husain, Mika A Sovak, Jing Yi, Lawrence R Nycum. J Clin Oncol 2012
781
20



B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin.
Yujia Cao, Lu Zhang, Yosuke Kamimura, Patcharee Ritprajak, Masaaki Hashiguchi, Sachiko Hirose, Miyuki Azuma. Cancer Res 2011
63
20

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas.
Ines Garces de Los Fayos Alonso, Huan-Chang Liang, Suzanne D Turner, Sabine Lagger, Olaf Merkel, Lukas Kenner. Cancers (Basel) 2018
41
20

Issues and promises of bevacizumab in prostate cancer treatment.
Vittore Cereda, Vincenzo Formica, Mario Roselli. Expert Opin Biol Ther 2018
11
20

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Robert L Coleman, Mark F Brady, Thomas J Herzog, Paul Sabbatini, Deborah K Armstrong, Joan L Walker, Byoung-Gie Kim, Keiichi Fujiwara, Krishnansu S Tewari, David M O'Malley,[...]. Lancet Oncol 2017
243
20

Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Chen Liu, Xuemei Peng, Yonghao Li, Shu Liu, Rentao Hou, Yewei Zhang, Shi Zuo, Zhan Liu, Rongcheng Luo, Libo Li,[...]. Biomed Pharmacother 2020
16
20

PD-L1 Influences Cell Spreading, Migration and Invasion in Head and Neck Cancer Cells.
Jonas Eichberger, Daniela Schulz, Kristian Pscheidl, Mathias Fiedler, Torsten Eugen Reichert, Richard Josef Bauer, Tobias Ettl. Int J Mol Sci 2020
3
33

Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis.
Ling Lu, Yonghong Li, Rong Luo, Junhui Xu, Jie Feng, Mingqiang Wang. Front Oncol 2020
6
20

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.
Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias,[...]. J Clin Oncol 2014
766
20

Cancer immunotherapy comes of age.
Suzanne L Topalian, George J Weiner, Drew M Pardoll. J Clin Oncol 2011
287
20

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
K Abiko, N Matsumura, J Hamanishi, N Horikawa, R Murakami, K Yamaguchi, Y Yoshioka, T Baba, I Konishi, M Mandai. Br J Cancer 2015
348
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.